2023 /PRNewswire/ -- Persephone Biosciences Inc., a synthetic biology company reimagining patient health through the microbiome, and Ginkgo Bioworks (NYSE: DNA), which is building the leading ...

Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit

Assembly Bio will receive $100 million, $84.8 million upfront payment and a $15.2 million equity investment, from Gilead. Gilead has the right to appoint two individuals to Assembly Bio's board ...

Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why

AUSTIN, Texas--(BUSINESS WIRE)--Pattern Bioscience, Inc., an innovator in rapid diagnosis and antibiotic susceptibility testing for bacterial infections, today announced the appointments of Tim ...

Pattern Bioscience Strengthens Leadership Team with Key Appointments

Assembly Biosciences (NASDAQ:ASMB) stock is taking off on Tuesday after announcing a massive collaboration with Gilead Sciences (NASDAQ:GILD). According to a press release, these two companies ...

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?

Shares of Assembly Biosciences more than doubled in premarket trading Tuesday after the biotechnology company inked a collaboration deal potentially worth hundreds of millions of dollars with ...

Assembly Biosciences Shares Soar Premarket on Gilead Pact

Evelo Biosciences said it is reviewing strategic alternatives after its Phase 2 clinical trial of EDP2939 for the treatment of moderate psoriasis failed to meet its primary endpoint. Chief ...

Evelo Biosciences Reviewing Alternatives After Study Didn't Meet Endpoint

“Working with Revvity will allow us to greatly expand the reach of high-quality sequencing as part of a complete solution for the benefit of customers everywhere,” said Yaron Hakak, SVP of corporate and business development at Element Bioscience

Revvity and Element Biosciences Announce Collaboration to Improve Next Generation Sequencing Research Workflow

JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, announced today completion of a D ...

Atom Bioscience Raises $83M in a D-Round Financing…

Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter: These 15 analysts have an average price target of $54.2 versus the current price of ...

Analyst Ratings for Harmony Biosciences

Piper Sandler analyst David Amsellem reiterated a Buy rating on Harmony Biosciences Holdings (HRMY – Research Report) today and set a price target of $42.00. The company’s shares closed last ...

Piper Sandler Sticks to Its Buy Rating for Harmony Biosciences Holdings (HRMY)

Harmony Biosciences Holdings Inc HRMY announced topline results from the INTUNE Phase 3 study of pitolisant in patients with idiopathic hypersomnia (IH). Idiopathic hypersomnia is a central ...

Why Is Sleep Disorder Related Harmony Biosciences Stock Trading Lower Today?

SAN DIEGO, CA / ACCESSWIRE / October 13, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage company applying transformative chemistry to improve prescription ...

Ensysce Biosciences, Inc.: Ensysce Biosciences Releases "Highlights Video" of PAINWeek 2023 Symposium

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has earned a Top ...

Castle Biosciences Ranked Third Among 2023 Top Workplaces in the Healthcare Industry

CAMBRIDGE, Mass., Oct. 13, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and INGENIA Therapeutics, a preclinical-stage biotech company with a breakthrough technology to ...

Nona Biosciences and INGENIA Therapeutics Enter into Collaboration Agreement

Somu Subramaniam, Board Member at Ventyx Biosciences VTYX, reported a large insider sell on October 11, according to a new SEC filing. Ventyx Biosciences shares are trading down 1.19% at $20.01 at ...

Board Member of Ventyx Biosciences Makes $1.48M Sale

Lexaria now holds 37 granted patents world-wide Potential application in treating nicotine addiction KELOWNA, BC / ACCESSWIRE / October 12, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ ...

Lexaria Bioscience Corp.: Lexaria Granted Two New Patents in Canada

On October 9, 2023, Wenbin Jiang, President and CEO of Cytek Biosciences Inc (NASDAQ:CTKB), sold 20,000 shares of the company. This move is part of a series of transactions made by the insider over the past year. Warning! GuruFocus has detected 4 Warning ...

Insider Sell: Cytek Biosciences Inc President and CEO Wenbin Jiang Sells 20,000 Shares

Kanvas Biosciences, the leader in microbiome mapping technology, today announced it acquired two active therapeutics programs, a microbial library, and intellectual property from Federation Bio ...

Kanvas Biosciences Acquires Federation Bio Assets to Scale the Discovery, Development and Manufacturing of Microbiome-Based Therapeutics

The combined company will have a unique advantage: Renovaro Biosciences’ pre-clinical and clinical trial data could be utilized to accelerate GEDi Cube’s AI capabilities that, in turn ...

GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine

These 8 analysts have an average price target of $35.5 versus the current price of IDEAYA Biosciences at $26.92, implying upside. Below is a summary of how these 8 analysts rated IDEAYA ...

Where IDEAYA Biosciences Stands With Analysts

What is your assessment the biosciences ecosystem in Florida? The life sciences industry throughout the state is strong. Data in Florida shows the industry now consists of 8,600 establishments ...

Biosciences conference kicks off in Ponte Vedra

IDEAYA Biosciences (NASDAQ:IDYA) has observed the following analyst ratings within the last quarter: These 8 analysts have an average price target of $35.5 versus the current price of IDEAYA ...

Live moderated webcast with Jeffrey Eisenberg, Chief Executive Officer of Xenetic Biosciences on Tuesday, October 24 th at 1:00 PM ET FRAMINGHAM, MA / ACCESSWIRE / October 11, 2023 / Xenetic ...

Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference

TAMPA, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions ...

Pacira BioSciences Announces Leadership Succession Plan

Sidero Bioscience

Startups from all over the world were nominated, from North America to East Asia. In total, 44,000 startups were nominated in over 4,500 cities.

Meet the Winners of Startups in North and Central America

Iron deficiency, anemia, anemia management, medical foods. 

SIDERO BIOSCIENCE

siderobio.com

Since 2007

Sidero Bioscience's stories on HackerNoon

Meet the Winners of Startups in North and Central America

Sidero Bioscience's latest news & mentions

Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit

Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why

Pattern Bioscience Strengthens Leadership Team with Key Appointments

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?

Assembly Biosciences Shares Soar Premarket on Gilead Pact

Evelo Biosciences Reviewing Alternatives After Study Didn't Meet Endpoint

Revvity and Element Biosciences Announce Collaboration to Improve Next Generation Sequencing Research Workflow

Atom Bioscience Raises $83M in a D-Round Financing…

Analyst Ratings for Harmony Biosciences

Piper Sandler Sticks to Its Buy Rating for Harmony Biosciences Holdings (HRMY)

Why Is Sleep Disorder Related Harmony Biosciences Stock Trading Lower Today?

Ensysce Biosciences, Inc.: Ensysce Biosciences Releases "Highlights Video" of PAINWeek 2023 Symposium

Castle Biosciences Ranked Third Among 2023 Top Workplaces in the Healthcare Industry

Nona Biosciences and INGENIA Therapeutics Enter into Collaboration Agreement

Board Member of Ventyx Biosciences Makes $1.48M Sale

Lexaria Bioscience Corp.: Lexaria Granted Two New Patents in Canada

Insider Sell: Cytek Biosciences Inc President and CEO Wenbin Jiang Sells 20,000 Shares

Kanvas Biosciences Acquires Federation Bio Assets to Scale the Discovery, Development and Manufacturing of Microbiome-Based Therapeutics

GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine

Where IDEAYA Biosciences Stands With Analysts

Biosciences conference kicks off in Ponte Vedra

Where IDEAYA Biosciences Stands With Analysts

Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference

Pacira BioSciences Announces Leadership Succession Plan

Representing this company? Click here to claim and customize this page!

Reviews About Sidero Bioscience

Sidero Bioscience WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

Light-Mode

Classic

Newspaper

Dark-Mode

Neon Noir

Minty

HN StartUps